Lenacapavir in Clinical Practice – A Primer for Clinicians
In the first webinar of the series, faculty – including principal investigators from the PURPOSE trials – review clinical data and delve into opportunities and challenges for the real-world implementation of lenacapavir as PrEP.
This webinar covers medication administration, managing side effects, potential drug interactions, and transitioning patients on or off lenacapavir as PrEP.
Learning Objectives:
- Summarize the key clinical trial data that supported FDA approval of lenacapavir for HIV prevention.
- Identify appropriate patient populations for lenacapavir as PrEP.
- Explain the administration process, dosing schedule, and monitoring requirements for lenacapavir as PrEP.
- Discuss practical implementation strategies, including counseling points, reimbursement, and barriers to uptake of lenacapavir PrEP.
Faculty:
- Colleen Kelley, MD, MPH, Emory University
- Onyema Ogbuagu, MBBCh, FACP, FIDSA, Yale School of Medicine
- Hyman Scott, MD, MPH, Bridge HIV in the San Francisco Department of Public Health
Other Related Trainings
Transforming PrEP Navigation and Empowering Patients through Long-acting Injectable PrEP
This webinar covers patient navigation touchpoints along the PrEP continuum for injectable lenacapavir, patient education strategies, expanding the capacity of PrEP navigation staff to implement injectable PrEP, and future opportunities for expanded implementation in mobile health settings.
PrEP: Preventing HIV in Women Across the Lifespan
This webinar will highlight the importance of engaging women in HIV prevention at each stage of life, including strategies for engagement and barriers to care.
